OCM
FOLD

Osterweis Capital Management’s Amicus Therapeutics FOLD Stock Holding History

Osterweis Capital Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-250,935
Closed -$1.44M – 287
2025
Q2 		$1.44M Sell
250,935
-573,805
-70% -$3.7M 0.07% 100
2025
Q1 		$6.73M Buy
+824,740
New +$7.63M 0.33% 74
2024
Q4 		– Sell
-884,820
Closed -$9.45M – 202
2024
Q3 		$9.45M Buy
884,820
+195,395
+28% +$2.13M 0.48% 65
2024
Q2 		$6.84M Buy
689,425
+205,365
+42% +$2.11M 0.35% 74
2024
Q1 		$5.7M Buy
+484,060
New +$6.19M 0.33% 78
2020
Q2 		– Sell
-241,002
Closed -$2.23M – 117
2020
Q1 		$2.23M Sell
241,002
-290,280
-55% -$2.76M 0.18% 82
2019
Q4 		$5.17M Buy
531,282
+66,267
+14% +$607K 0.36% 61
2019
Q3 		$3.73M Buy
465,015
+60,235
+15% +$654K 0.27% 70
2019
Q2 		$5.05M Sell
404,780
-54,050
-12% -$686K 0.36% 59
2019
Q1 		$6.24M Buy
+458,830
New +$5.6M 0.39% 63

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Osterweis Capital Management's FOLD Position: Q3 2025 in Review

Osterweis Capital Management sold out of Amicus Therapeutics (FOLD) in Q3 2025, closing a stake of 250,935 shares — an estimated $1.44M sold.

Osterweis Capital Management first reported a position in FOLD in Q1 2019 and held it in 10 quarters. The position peaked at $9.45M in Q3 2024. 287 funds tracked by Wall St. Rank hold FOLD as of Q3 2025.

  • Osterweis Capital Management reported no remaining Amicus Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Osterweis Capital Management sold 250,935 Amicus Therapeutics shares in Q3 2025, an estimated $1.44M.
  • Osterweis Capital Management first reported a position in Amicus Therapeutics in Q1 2019 and held it in 10 quarters.
  • Osterweis Capital Management's Amicus Therapeutics position peaked at $9.45M in Q3 2024.
  • 287 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2025.

Based on Osterweis Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.